| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 32.45% | Piper Sandler | → $2 | Downgrades | Overweight → Neutral |
| 01/06/2023 | 297.35% | UBS | $10 → $6 | Maintains | Buy |
| 09/07/2022 | 396.69% | Truist Securities | → $7.5 | Initiates Coverage On | → Hold |
| 10/20/2021 | 893.38% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 09/13/2021 | — | Piper Sandler | Upgrades | Neutral → Overweight | |
| 09/10/2021 | 827.15% | Cowen & Co. | → $14 | Initiates Coverage On | → Outperform |
| 07/01/2021 | 827.15% | Piper Sandler | → $14 | Initiates Coverage On | → Neutral |
What is the target price for CareMax (CMAX)?
The latest price target for CareMax (NASDAQ: CMAX) was reported by Piper Sandler on November 10, 2023. The analyst firm set a price target for $2.00 expecting CMAX to rise to within 12 months (a possible 32.45% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CareMax (CMAX)?
The latest analyst rating for CareMax (NASDAQ: CMAX) was provided by Piper Sandler, and CareMax downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for CareMax (CMAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareMax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareMax was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating CareMax (CMAX) correct?
While ratings are subjective and will change, the latest CareMax (CMAX) rating was a downgraded with a price target of $0.00 to $2.00. The current price CareMax (CMAX) is trading at is $1.51, which is within the analyst's predicted range.